Sign inJoin waitlistJoin the waitlist

Lauren Pommert

Assistant Professor of Clinical-Affiliate · University of Cincinnati Medical Center Inc.

Credentials: · · · ·

History

University of Cincinnati Medical Center Inc.
Present
Cincinnati Children's Hospital Medical Center
Present

Medical College of Wisconsin - Milwaukee
2016–2019
Internal Medicine
SSM Health/Saint Louis University School of Medicine
2013–2016
Saint Louis University School of Medicine
2009–2013

Research

Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis
Blood Advances · 2017 · 103 citations
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia
Blood Advances · 2022 · 47 citations
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium
American Journal of Hematology · 2022 · First of 27 authors · 41 citations

Eric Schafer
6 papers
Michael Burke
6 papers
Erin Breese
5 papers
Maureen O'Brien
5 papers
Benjamin Mizukawa
4 papers
Christine Phillips
4 papers
Deepa Bhojwani
4 papers
John Perentesis
4 papers
Sridhar Rao
4 papers
Alan Wayne
3 papers
Amy Moskop
3 papers · 2 as a fellow
BC
Bill Chang
3 papers

Clinical trials

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Principal investigator · Recruiting
Children's Hospital Medical Center, Cincinnati
2023–2027
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Site PI · Recruiting · Phase 1
Allterum Therapeutics, Inc
2026–2028
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Site PI · Recruiting · Phase 1
St. Jude Children's Research Hospital
2024–2027
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Site PI · Recruiting · Phase 1, Phase 2
PedAL BCU, LLC
2022–2030